This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's Stop Trading: Rite Aid Is Now an Earnings Story

NEW YORK (TheStreet) -- On CNBC's "Cramer's Stop Trading" segment, Jim Cramer said Rite Aid (RAD - Get Report) is taking the pharmacy industry by storm along with CVS Caremark (CVS) and Walgreen (WAG). The three companies -- an oligopoly -- are squeezing the middle man. 

Rite Aid is no longer a turnaround story, Cramer said, it is an earnings story. The company's 5% same store sales increase beat his expectations of 3% to 4% growth. 

Cardinal Health (CAH) and Express Scripts Holding (ESRX) each reported bad numbers, he said. The HMOs are winning, the drug stores are winning and the middle men are losing, he said.

Cramer says Yelp (YELP - Get Report) sparked the 'algorithm of the Internet' when it did well in he quarter.

"It's almost as if a machine says,'Oh, good!'" on Yelp results, "'We've got to buy  Facebook (FB), Workday (WDAY) and Concur Technologies (CNQR),'" Cramer said. And you've got a move all at once to to these Internet companies.

-- Written by Anthony Buccino in New York.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
RAD $8.39 0.00%
YELP $38.18 0.00%
AAPL $126.44 0.00%
FB $87.28 0.00%
GOOG $523.40 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs